Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795
Herpes simplex viruses type-1 (HSV-1) and type-2 (HSV-2) are ubiquitous human pathogens causing serious pathologies in the ocular, orofacial and anogenital regions. While current treatments such as nucleoside analogs are effective in most cases, the emergence of drug resistance necessitates the deve...
Main Authors: | Tejabhiram Yadavalli, Sudhanshu Kumar Singh, Abhijit A. Date, Deepak Shukla |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223008466 |
Similar Items
-
Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1
by: Ilina Bhattacharya, et al.
Published: (2022-04-01) -
BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2
by: Yogesh Sutar, et al.
Published: (2021-11-01) -
Effects of processing method on the pharmacokinetics and tissue distribution of orally administered ginseng
by: Jianbo Chen, et al.
Published: (2018-01-01) -
BX795, a kinase inhibitor, inhibit duck plague virus infection via targeting US3 kinase
by: Yanming Tian, et al.
Published: (2023-05-01) -
Diagnosis of Mucocutaneous Herpetic Infections by PCR without DNA Extraction
by: Mauricio L Nogueira, et al.
Published: (1998-03-01)